Joseph Asante Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2025 Last refreshed 2026-05-16

unknown

2 h-index 6 pubs 19 cited

Research Areas

OverviewAI-generated summary

Joseph Asante's research investigates the relationship between prescription drug use and the risk of Alzheimer's disease and related dementias. His work explores how specific drug classes, such as P-glycoprotein substrates, may impact amyloid-beta peptide transport in the brain and influence disease aggregation. Asante has also conducted predictive modeling studies on the structural and functional effects of SARS-CoV-2 spike protein mutations.

His publications include research on the association of prescription drug use with Alzheimer's disease risk, the impact of P-glycoprotein substrates on amyloid-beta peptide transport, and the potential of ezetimibe to reduce Alzheimer's risk by inhibiting specific protein interactions. Asante has a current h-index of 3 based on 9 publications. He has collaborated with researchers from the University of Arkansas for Medical Sciences, including Steven W. Barger, Corey Nagel, Robert J. Shmookler Reis, and Akshatha Ganne.

Metrics

h-index: 2
Publications: 6
Citations: 19

Selected Publications

Impact of P-Glycoprotein Substrates on Transendothelial Transport of Amyloid-β Peptide (2025)

DOI OpenAlex
Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study (2025)

1 citation DOI OpenAlex
P-glycoprotein and Alzheimer’s Disease: Threats and Opportunities (2025)

DOI OpenAlex
Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction (2024)

10 citations DOI OpenAlex